We are live on ! Find out more
VTRS icon

Viatris

520 hedge funds and large institutions have $15.5B invested in Viatris in 2018 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 200 increasing their positions, 173 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 200 | Existing positions reduced: 173

0% more funds holding in top 10

Funds holding in top 10: 2020 (0)

4% less call options, than puts

Call options by funds: $301M | Put options by funds: $314M

8% less first-time investments, than exits

New positions opened: 61 | Existing positions closed: 66

1.17% less ownership

Funds ownership: 84.98%83.81% (-1.2%)

2% less funds holding

Funds holding: 530520 (-10)

14% less capital invested

Capital invested by funds: $18.1B → $15.5B (-$2.53B)

Holders
520
Holders Change
-10
Holders Change %
-1.89%
% of All Funds
11.9%
Holding in Top 10
20
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.46%
New
61
Increased
200
Reduced
173
Closed
66
Calls
$301M
Puts
$314M
Net Calls
-$13.3M
Net Calls Change
-$162M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$120M -$94.4M -2,405,738 -42%
HIIFS
27
Harel Insurance Investments & Financial Services
Israel
$119M -$1.2M -30,711 -0.9%
TCIM
28
TIAA CREF Investment Management
New York
$117M -$6.19M -157,814 -5%
Russell Investments Group
29
Russell Investments Group
United Kingdom
$98.4M -$1.78M -45,333 -2%
Franklin Resources
30
Franklin Resources
California
$93.6M +$51.5M +1,314,000 +103%
ClearBridge Investments
31
ClearBridge Investments
New York
$91.5M -$422K -10,756 -0.4%
CCM
32
Camber Capital Management
Massachusetts
$90.3M +$49M +1,250,000 +100%
Legal & General Group
33
Legal & General Group
United Kingdom
$89.7M -$1.08M -27,592 -1%
DG
34
Delek Group
Israel
$82.9M +$4.29M +109,388 +5%
Charles Schwab
35
Charles Schwab
California
$80.9M +$9.93M +253,082 +13%
TA
36
Teachers Advisors
New York
$75.1M -$5.46M -139,293 -6%
BGIM
37
Brandywine Global Investment Management
Pennsylvania
$73.4M -$3.14M -80,159 -4%
Alyeska Investment Group
38
Alyeska Investment Group
Illinois
$71.8M +$22.9M +584,832 +42%
Schroder Investment Management Group
39
Schroder Investment Management Group
United Kingdom
$68.6M -$13.3M -339,472 -15%
Massachusetts Financial Services
40
Massachusetts Financial Services
Massachusetts
$65.4M +$162K +4,142 +0.2%
MIFH
41
Migdal Insurance & Financial Holdings
Israel
$63M -$5.6M -142,709 -8%
DM
42
Deerfield Management
New York
$63M -$31.6M -806,000 -32%
MIH
43
Meitav Investment House
Israel
$61.7M +$4.18M +106,585 +7%
Swiss National Bank
44
Swiss National Bank
Switzerland
$61.5M +$9.34M +238,200 +16%
Jennison Associates
45
Jennison Associates
New York
$60.3M +$9.12M +232,483 +16%
TCM
46
Tekla Capital Management
Massachusetts
$59.9M -$2.74M -69,950 -4%
O
47
OppenheimerFunds
New York
$58.5M +$376K +9,584 +0.6%
UBS Group
48
UBS Group
Switzerland
$58.4M -$23.1M -587,697 -27%
UBS AM
49
UBS AM
Illinois
$57.9M +$2.2M +56,149 +4%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$57.1M +$28.6M +727,972 +85%

VTRS Hedge Fund Activity: Q2 2018 in Review

520 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q2 2018, worth a combined $15.5B — down 14% from $18.1B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of VTRS and 61 opened new positions — a net loss of 5 holders — while 173 trimmed existing stakes and 200 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $301M. The largest seller was Goldman Sachs, cutting an estimated $432M.

  • 520 institutional investors held Viatris (VTRS) as of Q2 2018, down from 530 in Q1 2018.
  • Funds reported $15.5B of Viatris stock for Q2 2018, down 14% quarter-over-quarter.
  • 61 funds opened new Viatris positions in Q2 2018 and 66 closed out, a net change of -5 holders.
  • The largest Viatris buyer in Q2 2018 was Capital World Investors, an estimated $301M added.
  • The largest Viatris seller in Q2 2018 was Goldman Sachs, an estimated $432M sold.

Based on aggregated 13F filings for Q2 2018.